This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires | MicrobiomeTrials
← Back to trials NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2023-03-03Est. Completion: 2027-05-31
Enrollment target: 100 participantsLocations National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland, United States Other microbiome trials you might be interested in Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United States Est. completion Apr 22, 2030
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease. Patients report that fatigue has a significant im…
Edinburgh, United Kingdom Est. completion Mar 9, 2026